Discover 3,059 paid clinical trials in Cambridge, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease
for
High-Risk Oral Precancerous Disease
Location: Boston MA
Sponsor: Glenn J. Hanna
Sex: All
Age: 18+
Code: NCT06623110
Phase 2, Recruiting
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa (HS)
Location: Boston MA, Farmington CT, Danville PA, Baltimore MD,
Sponsor: Incyte Corporation
Sex: All
Age: 12 - 17
Code: NCT07213973
Phase 2, Recruiting
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
for
Fibromyalgia
Location: Watertown MA, Boston MA, Cranston RI, Cromwell CT,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07398417
Phase 3, Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
for
Osteoarthritis, Overweight or Obesity
Location: Burlington MA, Quincy MA, Long Island City NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07353931
Phase 3, Recruiting
Refining Local-Regional Therapy for IBC
for
Breast Cancer, Inflammatory Breast Cancer, Sentinel Lymph Node
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: Female
Age: 18+
Code: NCT04636710
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
for
Congenital Diaphragmatic Hernia
Location: Boston MA, Ann Arbor MI, Indianapolis IN, Charleston SC,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0
Code: NCT05213676
Recruiting
Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
for
Dementia, Alzheimers Disease,
Location: Boston MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 60 - 70+
Code: NCT06489548
Phase 2, Recruiting
Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study
for
Breast Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: Female
Age: 70+
Code: NCT07123649
Phase 2, Recruiting
TRUDI: TDXD+Durva in HER2+/Low IBC
for
Invasive Breast Cancer, Inflammatory Breast Cancer Stage III,
Location: Boston MA, Houston TX
Sponsor: Filipa Lynce, MD
Sex: Female
Age: 18+
Code: NCT05795101
Phase 2, Recruiting
ETHAN - ET for Male BC
for
Male Breast Cancer, Hormone Receptor-positive Breast Cancer,
Location: Boston MA, Philadelphia PA, Washington D.C. DC,
Sponsor: Jose Pablo Leone
Sex: Male
Age: 18+
Code: NCT05501704
Phase 2, Recruiting
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
for
Graft Vs Host Disease
Location: Boston MA, Rochester NY, Chicago IL, Atlanta GA
Sponsor: Boston Children's Hospital
Sex: All
Age: 2+
Code: NCT04380740
Phase 2, Recruiting
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Location: Boston MA, Scarborough ME, Montreal, Philadelphia PA,
Sponsor: Turning Point Therapeutics, Inc.
Sex: All
Age: 0 - 25
Code: NCT04094610
Phase 1, Phase 2, Recruiting
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
for
Overweight, Obesity
Location: Boston MA, Waltham MA, Waterbury CT, New Haven CT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07392190
Phase 3, Recruiting
Early Intervention in High Risk CCUS
for
Clonal Cytopenia of Undetermined Significance, Cytopenia
Location: Boston MA
Sponsor: Lachelle D. Weeks, MD, PhD
Sex: All
Age: 18+
Code: NCT06802146
Early Phase 1, Recruiting
Observational Study of THC Concentrations in Acute Cannabis-induced CNS Depression
for
Acute Cannabis-induced CNS Depression
Location: Worcester MA, Cincinnati OH, Portland OR
Sponsor: Anebulo Pharmaceuticals
Sex: All
Age: 0+
Code: NCT06017622
Recruiting
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Boston MA, Rochester NY, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 65+
Code: NCT06042569
Phase 2, Recruiting
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)